T 1214/17 (Pharmaceutical solutions/UCB PHARMA) of 19.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T121417.20210319
- Date of decision
- 19 March 2021
- Case number
- T 1214/17
- Petition for review of
- -
- Application number
- 09716304.2
- IPC class
- A61K 31/4015A61K 9/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL SOLUTIONS, PROCESS OF PREPARATION AND THERAPEUTIC USES
- Applicant name
- UCB Pharma, S.A.
- Opponent name
- Hollatz, Christian
Generics [UK] Limited (trading as Mylan) - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2) (2007)European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention R 116(1) (2007)European Patent Convention R 152 (2007)Rules of procedure of the Boards of Appeal Art 12 (2007)
- Keywords
- Authorisation - filing of authorisation
Late submitted material - document admitted (no)
Novelty - (yes)
Inventive step - (no) - Catchword
- -
- Citing cases
- T 2342/19
Order
For these reasons it is decided that:
5. The appeal is dismissed
6. The requests of the appellant that the appeal fee be reimbursed and that the respondent be ordered to bear the appellant's costs incurred in relation to the oral proceedings before the opposition division are rejected.